Poulton Stuart - Insider Non-Derivative Transactions at Karyopharm Therapeutics Inc. (KPTI) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jul 30, 2024, Poulton Stuart's relationship to Karyopharm Therapeutics Inc. (KPTI) is Officer (EVP, Chief Development Officer), and currently has 326,628 shares of Common Stock, and 329,511 shares of Common.

The the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KPTI insiders.

Data Source: SEC.
Poulton Stuart - Insider Non-Derivative Transactions of KPTI Common Stock
Poulton Stuart - Insider Non-Derivative Transactions of KPTI Common
Poulton Stuart - Insider Non-Derivative Transactions at KPTI
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jul 31, 2024 Sell -- (Common Stock) 2883 1.06 326628
Mar 2, 2024 Sell -- (Common) 6155 1.2 329511
Mar 1, 2024 Sell -- (Common) 16311 1.17 335666
Feb 29, 2024 Acquisition -- (Common Stock) 188205 0 351977
Feb 16, 2024 Sell -- (Common Stock) 99 1.4 163772
Feb 16, 2024 Sell -- (Common Stock) 5748 1.33 163871
Jan 25, 2024 Acquisition -- (Common Stock) 13333 0 169619
Jul 29, 2023 Sell -- (Common Stock) 2845 1.7 156286
Mar 1, 2023 Acquisition -- (Common Stock) 95000 0 159131
Feb 16, 2023 Sell -- (Common Stock) 196 3.16 64131
Feb 16, 2023 Sell -- (Common Stock) 8 3.23 64327
Feb 16, 2023 Sell -- (Common Stock) 5665 3.19 64335